| 腿 | 交易所 | 价格 | 费率 /8h | 每次结算 | 距下次结算 | OI | 24h 成交量 | 杠杆 | |
|---|---|---|---|---|---|---|---|---|---|
| 做多 | 132.69 | +0.0050 | 支付 0.0006% / 1h | 0m 49s | $735K | $820K | 10x | 做多 Ondo Perps减 5% | |
| 做空 | 132.89 | 0 | 0.0000% / 8h | 3h 00m | $106K | $21K | 20x | 做空 Aster返 ≤10% |
价差+0.153%57s
资金费率差−0.0050% /8h
若价差回到其 7 日均值,$10k 仓位可得 +$3,但每天要支付 $2 资金费,约 2.1 天就会耗尽这部分收益。
两个价格的读取时间相差 57 秒:这一价差中有一部分可能来自行情变动。
现在开仓并持有
每条腿 $10k · 为过去 7D 的实际数据,并非预测资金费率−$10当前 −0.0050% /8h · 过去 7D 已结算 −0.100%
价格—当前价差 +0.153%57s · 两个价格读取时间相差过大,无法比较
成本无数据Ondo Perps 没有订单簿数据
资金费率历史
你收取你支付均值
区间统计 · 7D
平均 /8h—
最高—
最低—
收到资金费—
空头腿费率减去多头腿费率(每 8 小时)。大于零:该组合向你支付资金费。
两家交易所之间的价差
Aster 相对 Ondo Perps 的价格当前
区间统计 · 7D
当前+0.153%
平均—
区间—
比当前更宽—
过去 7D 的价差分布▾
各水平所占的时间比例
所有交易所的资金费率
/8h29 家交易所的 ORCL
资金费率从低到高开仓前检查
2 项正常 · 3 项需留意- 说明: 订单簿未知—Ondo Perps 没有订单簿样本:未计入其滑点。
- 说明: 最高杠杆下的保证金$1,000 + $500Ondo Perps 10x,Aster 20x。建议准备约 2 倍的保证金,以免行情剧烈波动时其中一条腿被强平。
- 需留意: 结算周期不同1h / 8h两条腿的结算时间不同。请在周期较长的那条腿结算后立即平仓。按当前费率,每条腿 $10k,未来 24 小时:−$1.51做多 Ondo Perps:24 次结算,−$1.51;做空 Aster:3 次结算,$0.00。
- 需留意: 价格读取时间相差 57 秒+0.153% vs +0.121%这一价差中有一部分可能来自行情变动。
- 需留意: 空头腿深度较薄$106K vs $735K OI平仓成本取决于 Aster。平仓前请先查看其订单簿。
- 正常: 有一条腿可赚积分Ondo Perps 积分 · Aster 第 5 阶段在此产生的成交量计入积分计划。
- 正常: 两条腿均无需 KYCOndo Perps 无需 · Aster 无需两家交易所均无需身份验证即可交易。
收益计算器
两条腿,含开仓和平仓每条腿仓位持有时间订单类型价差资金费率
资金费收益−0.0047%/8h × 21 个周期−$9.97
价差两个价格读取时间相差过大,无法比较—
滑点,4 笔订单Ondo Perps 无数据—
Ondo Perps 手续费 bp × 2 笔订单−$5.00
Aster 手续费 bp × 2 笔订单−$8.00
净收益(仅扣手续费) · 7 天 · $10k−$22.97
未计入价差:两个价格读取时间相差过大需覆盖的成本0.130%回本时间按此费率无法回本
滑点:Ondo Perps:没有订单簿样本;Aster:实时订单簿,40 分钟前开仓成本
吃单手续费 + 相对中间价的滑点,单边买入 · 做多Ondo Perps—————
卖出 · 做空Aster30.3747.4 bp−$4781.2 bp−$812容纳不下容纳不下
平仓还需再付大致相同的成本。
Ondo Perps:无数据。
| 09-28 17:30 | Vest Markets | 其他 | Oracle's AI financing model is drawing fresh skepticism, with $ORCL down around 2.7% on the session. S&P lowered the credit rating to BBB-, the shares drew a Sell rating this morning, and five-year default swaps reached a record 227 basis points last week. The $18B of debt tied to Project Jupiter is quoted near 89 cents on the dollar, with about half of Oracle's $664B backlog tied to OpenAI. X 上的 @VestExchange ↗ |
| 09-27 09:40 | Kalshi | 其他 | JUST IN: Oracle reportedly gave Larry Ellison and co-CEOs nearly $1 billion in stock options that "had no value" by fiscal year-end X 上的 @Kalshi ↗ |
| 09-25 03:59 | Kalshi | 其他 | JUST IN: Oracle's "investment grade" bond closed at 8.10%, in line with B3/B- junk X 上的 @Kalshi ↗ |
| 09-24 13:30 | Vest Markets | 其他 | $ORCL is down around 5.4% into the open, with a reported force majeure notice to its New Mexico data center developer. The notice goes to developer Blue Owl on Project Jupiter, seeking to defer payments if the 1,400-acre campus behind Oracle's OpenAI capacity deal slips past 2028. Trade $ORCL volatility with a Vest Capital funded account and access up to $25k in trading capital. X 上的 @VestExchange ↗ |
| 09-21 19:10 | Avantis | 其他 | Size traders choose Veranta for RWA perps. On an orderbook, a $10M XAU clip walks the book: slippage blows out, funding spikes locally, and fills come back partial. Veranta has a hybrid AMM + RFQ trading engine, meaning: - RWA orders fill instantly against the vault. - At a fair and verifiable oracle price. - With spreads quoted by MMs from the most liquid real-world venues, at the depth those venues actually hold. You focus on the thesis. The liquidity is our problem. X 上的 @verantaxyz ↗ |
| 09-19 15:05 | Injective | 产品 | The Injective Meridian Mainnet Upgrade is now live for voting. Meridian advances Injective's position as the premier blockchain for institutional-grade tokenization while laying the foundation for the future CypherOS launch, Injective's native privacy platform. It expands support for regulated asset issuance with Injective's SEC transfer agent registration now deemed effective and unified RWA perpetual markets, enabling tokenized stocks and real-world assets to be issued, traded, and settled entirely onchain. The governance proposal can now be voted on by $INJ stakers on the Injective Hub with voting closing on September 22nd. If passed, the new mainnet upgrade is scheduled to occur on Thursday, September 24. Here is a summary of the Meridian Mainnet Upgrade: Institutional-Grade RWA Issuance Meridian brings support for regulated token implementations to the Injective EVM, allowing issuers to embed compliance and transfer requirements directly into tokenized products. This creates a purpose-built foundation for compliant RWA launches, tokenized equities, and new financial instruments on Injective. Unified Tokenized Perp Markets New MultiVM capabilities enable asset controls to operate consistently across Injective’s native and EVM environments. Support for atomic purchases through the exchange precompile also gives EVM applications more direct access to Injective’s native liquidity and settlement layer. Native Privacy Platform Alpha Meridian lays the foundation for privacy-focused infrastructure and introduces the initial testing of private RFQ transaction flows. These controlled execution environments are designed to give institutions access to onchain liquidity while protecting sensitive trading and order information. The testing introduced with Meridian prepares Injective for a broader suite of privacy features, culminating in the launch of CypherOS, Injective's native privacy platform, which is expected to be introduced in an upcoming chain upgrade. Resilient Markets and Oracle Performance The upgrade strengthens market execution, risk controls, transaction signing, and oracle processing. Improved oracle prioritization and relay validation provide more dependable pricing infrastructure for tokenized equities, RWAs, derivatives, and other advanced financial markets. Together, these capabilities position Injective as the unified network for bringing global financial assets onchain. If passed, this proposal will commit the Injective blockchain to halt at a target block height of 184394000 (approximately 15:00 UTC / 11:00 EDT on September 24th, 2026) and resume with the 1.20.4 version of the Injective Chain application binary soon after. X 上的 @injective ↗ |

Kalshi
Avantis
Injective